Filter Results:
(1,759)
Show Results For
- All HBS Web
(1,759)
- People (7)
- News (435)
- Research (981)
- Events (3)
- Multimedia (4)
- Faculty Publications (366)
Show Results For
- All HBS Web
(1,759)
- People (7)
- News (435)
- Research (981)
- Events (3)
- Multimedia (4)
- Faculty Publications (366)
- 08 Mar 2011
- First Look
First Look: March 8
impairment reporting and that its effect is better understood in the context of upper echelons theory and agency theory. Download the paper: http://www.hbs.edu/research/pdf/11-088.pdf Risky Trust: How Multi-entity Teams Develop Trust in a View Details
Keywords: Sean Silverthorne
Dennis A. Yao
Dennis Yao is the Lawrence E. Fouraker Professor of Business Administration and Chair of the Doctoral Programs at Harvard Business School. He joined the faculty in 2004 after having been at the Wharton School, University of Pennsylvania. From 1991-1994 he served as... View Details
- Article
Are All Certified EHRs Created Equal? Assessing the Relationship between EHR Vendor and Hospital Meaningful Use Performance
By: A Jay Holmgren, Julia Adler-Milstein and Jeffrey McCullough
Objective
The federal electronic health record (EHR) certification process was intended to ensure a baseline level of system quality and the ability to support meaningful use criteria. We sought to assess whether there was variation across EHR vendors in the... View Details
The federal electronic health record (EHR) certification process was intended to ensure a baseline level of system quality and the ability to support meaningful use criteria. We sought to assess whether there was variation across EHR vendors in the... View Details
Keywords: Hospitals; Electronic Health Records; Digital Health; Health Care and Treatment; Information Technology; Service Delivery; Performance Evaluation
Holmgren, A Jay, Julia Adler-Milstein, and Jeffrey McCullough. "Are All Certified EHRs Created Equal? Assessing the Relationship between EHR Vendor and Hospital Meaningful Use Performance." Journal of the American Medical Informatics Association 25, no. 6 (June 2018): 654–660. (Editor's Choice.)
- Article
Value-based Healthcare: Implications for Thyroid Cancer
By: A.K. Ying, T.W. Feeley and M. E. Porter
Today's delivery of care to thyroid cancer patients is complex, and costly, with uneven outcomes that can be improved. The incidence of thyroid cancer is rising and requires coordinated, multidisciplinary care with high volume centers that is not always available in... View Details
Keywords: Bundled Reimbursement; Healthcare Reform; Integrated Practice Units; Outcomes; Patient-reported Outcomes; Thyroid Cancer; Health Care and Treatment; Cost; Information Technology; Value
Ying, A.K., T.W. Feeley, and M. E. Porter. "Value-based Healthcare: Implications for Thyroid Cancer." International Journal of Endocrine Oncology 3, no. 2 (May 2016): 115–129. (e-Pub 4/2016.)
- February 1991
- Case
Burlington Northern: The ARES Decision (B)
By: Julie H. Hertenstein and Robert S. Kaplan
The ARES team formally proposes that Burlington Northern implement the ARES system. The project meets resistance. In light of financial restructuring and high level of debt, executives wonder whether the company can afford ARES. Weak links during the ARES development... View Details
Keywords: Accounting Audits; Restructuring; Cost vs Benefits; Decision Choices and Conditions; Borrowing and Debt; Capital Budgeting; Projects; Technology Adoption; Service Industry
Hertenstein, Julie H., and Robert S. Kaplan. "Burlington Northern: The ARES Decision (B)." Harvard Business School Case 191-123, February 1991.
Malcolm P. Baker
Malcolm Baker is the Robert G. Kirby Professor of Business Administration at the Harvard Business School, where he teaches the required course in finance and a short immersive program on investing in life sciences.
His research is in the... View Details
- Web
Executive Education - Leadership
in the Digital Era HBS Campus | 06–11 APR 2025 Drive growth by harnessing digital technologies and data analytics to build organizations that are agile, resilient, and sustainable. Advancing Women of Color in Leadership HBS Campus | 27–30... View Details
- 15 Jan 2007
- Research & Ideas
The Business of Free Software
IT vendors including Oracle, IBM, and Sun that traditionally have built offerings based on proprietary technologies are now investing billions of dollars into open source software—arrangements that are transforming in some ways the... View Details
- 20 Feb 2017
- News
MBAs in space: rocket science absorbs business school thinking
- 20 Oct 2010
- Working Paper Summaries
Financing Risk and Bubbles of Innovation
- Web
Marketing - Faculty & Research
the time and find comfort. Then, amid growing shortages in commodities, a vaccine arrived, businesses began to re-open, and consumers benefited from federal relief aid. This perfect storm of high demand amid stock shortages generated the... View Details
- March 2015
- Case
BOLT: Seed Venture Capital Firm
By: William A. Sahlman and Robert F. White
BOLT is a different kind of seed venture capital firm built to serve the needs of early-stage startups at the intersection of hardware and software.
In the past decade, the cost of entrepreneurial experimentation has dropped dramatically, particularly in web... View Details
In the past decade, the cost of entrepreneurial experimentation has dropped dramatically, particularly in web... View Details
Keywords: Entrepreneurial Finance; Accelerator; Entrepreneurship; Finance; Venture Capital; Applications and Software; Information Infrastructure; Strategy
Sahlman, William A., and Robert F. White. "BOLT: Seed Venture Capital Firm." Harvard Business School Multimedia/Video Case 815-702, March 2015.
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- 17 Jun 2014
- First Look
First Look: June 17
Highway: Technology and Mobility Trends and Opportunities Technological innovation is considered a competitive strength for America, but the nation does not score as high in... View Details
Keywords: Sean Silverthorne
- September 2017
- Case
NBCUniversal Telemundo: Transforming Latino Television
By: Henry W. McGee, Carin-Isabel Knoop and Christine Snively
In August 2017, Cesar Conde, chairman of NBCUniversal International Group and NBCUniversal Telemundo Enterprises, considered how the Miami-based Spanish-language TV network Telemundo could succeed in a rapidly shifting media landscape. Over the past few years,... View Details
Keywords: Television Industry; Television Advertising; Broadcasting; Telecommunications; Internet; Television Entertainment; Internet and the Web; Advertising; Digital Platforms; Digital Marketing; Telecommunications Industry; Media and Broadcasting Industry; Miami
McGee, Henry W., Carin-Isabel Knoop, and Christine Snively. "NBCUniversal Telemundo: Transforming Latino Television." Harvard Business School Case 318-018, September 2017.
Isamar Troncoso
Isamar Troncoso is an Assistant Professor of Business Administration in the Marketing Unit at HBS. She teaches the Marketing course in the MBA required curriculum.
Professor Troncoso studies problems related to digital marketplaces and new technologies. She... View Details
- Summer 2021
- Article
The Cost and Evolution of Quality at Cipla Ltd, 1935–2016
By: Muhammad H. Zaman and Tarun Khanna
This article examines the evolution of Indian pharmaceutical manufacturer Cipla towards producing drugs that met the quality standards of European and U.S. regulators. It employs new research in Cipla’s corporate archives, the Creating Emerging Markets database, and... View Details
Keywords: Cipla; Pharmaceuticals; Drug Quality; Generics; Quality; Standards; Information Technology; Cost; Organizational Culture; Business History; Pharmaceutical Industry; India
Zaman, Muhammad H., and Tarun Khanna. "The Cost and Evolution of Quality at Cipla Ltd, 1935–2016." Business History Review 95, no. 2 (Summer 2021): 249–274.
- 05 Apr 2016
- First Look
April 5, 2016
Teenagers for Business Careers after World War II By: Friedman, Walter A. Abstract—This article traces the growing popularity of Junior Achievement’s “Company Program” in the two decades after World War II. The program provided high... View Details
Keywords: Sean Silverthlorne
- 26 Nov 2013
- First Look
First Look: November 26
across funds. Controlling for fund performance, fund holdings with high past returns attract extra flows only if these stocks were recently featured in major newspapers. In contrast, holdings that were not covered in the media do not... View Details
Keywords: Sean Silverthorne
- Web
Podcasts - Managing the Future of Work
retention. Also, how technology can accelerate the adoption. Read the Transcript Previous Episodes The business logic of supporting carers in the workforce 23 OCT 2024 | Managing the Future of Work Employers can benefit by remapping their... View Details